MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo
Main Author: | Fiedler, L |
---|---|
Format: | Journal article |
Published: |
Elsevier
2019
|
Similar Items
-
Corin Overexpression Reduces Myocardial Infarct Size and Modulates Cardiomyocyte Apoptotic Cell Death
by: Ryan D. Sullivan, et al.
Published: (2020-05-01) -
Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction
by: Erik Klapproth, et al.
Published: (2022-12-01) -
Effects of MAP4K inhibition on neurite outgrowth
by: Di Ja Lasham, et al.
Published: (2023-11-01) -
Dipeptidylpeptidase 4 promotes survival and stemness of acute myeloid leukemia stem cells
by: Chen Wang, et al.
Published: (2023-02-01) -
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Deletion but Not Inhibition of Extracellular PCSK9 Reduces Infarct Sizes Ex Vivo but Not In Vivo
by: Rolf Schreckenberg, et al.
Published: (2022-06-01)